JPRN-UMIN000001999已完成1 期
The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigen - The clinical study of cancer vaccine for intractable malignant tumor
Department of Surgical Oncology, Hokkaido University Graduate School of Medicine0 个研究点目标入组 18 人开始时间: 2009年5月22日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •HIV positive, autoimmune diseases,pregnancy,breast feeding
研究者
相似试验
已完成
1 期
A phase I clinical study of cancer vaccine with MAGE-A4/Survivin helper peptide for patients with advanced cancers expressing MAGE-A4 or Survivin antigeMAGE-A4- or Survivin-expressing refractory cancer patients (non origin-limited) or patients who refuse standard cancer therapyJPRN-UMIN000003489Department of General Surgery, Hokkaido University Graduated School of Medicine12
已完成
不适用
A phase I clinical trial of cancer vaccine using multiple antigen epitope peptides for advanced cervical canceradvanced and recurrent cervical cancerJPRN-UMIN000003999Saitama medical university international medical center18
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent colorectal cancersSurvivin-expressing advanced/recurrent colorectal cancer patients or patients who refuse standard cancer therapyJPRN-UMIN000007506Department of Gastroenterological Surgery I, Hokkaido University Graduated School of Medicine35
已完成
2 期
A phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersA phase II clinical study of cancer vaccine with Survivin helper peptide for patients with advanced/recurrent breast cancersJPRN-UMIN000007507Department of Breast and Endocrine Surgery, Hokkaido University Hospital40
已完成
1 期
Phase I clinical study of tumor-specific vaccine using novel tumor antigen SCRN1-derived HLA*0201 restricted epitope peptide against advanced gastric cancerAdvanced gastric cancerJPRN-UMIN000001013Institute of Medical Science, University of Tokyo6